If you have any question, please feel free to email us. We will touch with you as soon as possible.
DOXOBREX 100MG INJECTION is indicated for the treatment of chronic obstructive pulmonary disease (COPD), bronchial asthma, and pulmonary disease with the spastic bronchial component. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Drug Generic Name | 多索茶碱注射液 |
|---|---|
| Trade Name | Doxofylline Injection |
| Brand Name | Ansimar |
| Dosage Form | Injection |
| Strength | 100 mg/10 mL |
| Holder | Abc Farmaceutici S.P.A |
| Remarks | Italy listing |
| Product Type | Reference Listed Drugs (RLDs) |
DOXOBREX 100MG INJECTION contains Doxofylline which belongs to the group of medicines called Bronchodilators. It is indicated for the treatment of chronic obstructive pulmonary disease (COPD), bronchial asthma, and pulmonary disease with the spastic bronchial component.
Looking for more information and services? Get in touch with us today!
Email: tosun-global@upharm.cn
Wechat/WhatsApp: (+86)189-2212-0575
Hot Tags: Doxofylline Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Argatroban Injection, AdapaleneGel, Esomeprazole Magnesium Enteric Coated Capsules, Bimatoprost Ophthalmic, Adefovir Dipivoxil Tablets, Acarbose Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
